Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Dashatinib in Multiple Sclerosis, Secondary Progressive: NCT07270120 Clinical Landscape Report 2026
15 October 2026
NCT07270120 clinical landscape for Multiple Sclerosis, Secondary Progressive: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
Cisplatin in Small Cell Carcinoma: NCT07276360 Clinical Landscape Report 2026
15 October 2026
NCT07276360 clinical landscape for Small Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Peritoneal Neoplasms: NCT07273396 Clinical Landscape Report 2026
15 October 2026
NCT07273396 clinical landscape for Peritoneal Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ivarmacitinib in Pustulosis of Palms and Soles: NCT07270003 Clinical Landscape Report 2026
15 October 2026
NCT07270003 clinical landscape for Pustulosis of Palms and Soles: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ivarmacitinib in Dermatitis, Atopic: NCT07276620 Clinical Landscape Report 2026
15 October 2026
NCT07276620 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Galvokimig in Dermatitis, Atopic: NCT07277660 Clinical Landscape Report 2026
15 October 2026
NCT07277660 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BCMA CAR-T Cell(Xuzhou Medical University) in Multiple Myeloma: NCT07280793 Clinical Landscape Report 2026
15 October 2026
NCT07280793 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Deucravacitinib in Arthritis, Psoriatic: NCT07280702 Clinical Landscape Report 2026
15 October 2026
NCT07280702 clinical landscape for Arthritis, Psoriatic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Methylphenidate Hydrochloride in Alzheimer Disease: NCT07279740 Clinical Landscape Report 2026
15 October 2026
NCT07279740 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cemsidomide in Multiple Myeloma: NCT07280013 Clinical Landscape Report 2026
15 October 2026
NCT07280013 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fisetin in Alzheimer Disease: NCT07279714 Clinical Landscape Report 2026
15 October 2026
NCT07279714 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Camibirstat in Acute Myeloid Leukemia: NCT07283094 Clinical Landscape Report 2026
15 October 2026
NCT07283094 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.